As a pioneer in the field of snake-derived biopharmaceuticals and holistic health, the company’s research and development efforts span from snake venom-based anticancer and cardiovascular and cerebrovascular disease treatments to holistic health supplements made from snake-derived traditional Chinese medicinal materials.
In the future, the company will conduct research and clinical studies on novel recombinant proteins, peptide drugs, and nucleic acid-based biotechnologies, focusing on key cutting-edge biotechnologies such as protein modification and the efficient expression of recombinant proteins.